-
Something wrong with this record ?
Recombinant activated factor VII administration after pulmonary embolectomy: case report
N. Omran, J. Harrer, M. Brtko, P. Habal, Z. Turek, M. Pojar, J. Brozik,
Language English Country United States
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Embolectomy adverse effects MeSH
- Factor VII administration & dosage genetics MeSH
- Coagulants administration & dosage MeSH
- Blood Coagulation Disorders complications drug therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Pulmonary Embolism complications surgery MeSH
- Postoperative Hemorrhage etiology prevention & control MeSH
- Recombinant Proteins adverse effects MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
Bleeding management in cardiac surgery could be a great challenge for the surgeon and a life-threatening moment for the patient. Despite the fact that recombinant activated factor VII is now widely accepted as a useful adjunct in the management of postcardiotomy coagulopathy, its use in the course of recent thromboembolic event is rarely described. We hereby present a case of rescue recombinant activated factor VII administration to manage a severe coagulation disorder during surgical pulmonary embolectomy performed under cardiopulmonary bypass.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14050843
- 003
- CZ-PrNML
- 005
- 20140410105034.0
- 007
- ta
- 008
- 140401s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1532/HSF98.20131026 $2 doi
- 035 __
- $a (PubMed)23958532
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Omran, Nedal
- 245 10
- $a Recombinant activated factor VII administration after pulmonary embolectomy: case report / $c N. Omran, J. Harrer, M. Brtko, P. Habal, Z. Turek, M. Pojar, J. Brozik,
- 520 9_
- $a Bleeding management in cardiac surgery could be a great challenge for the surgeon and a life-threatening moment for the patient. Despite the fact that recombinant activated factor VII is now widely accepted as a useful adjunct in the management of postcardiotomy coagulopathy, its use in the course of recent thromboembolic event is rarely described. We hereby present a case of rescue recombinant activated factor VII administration to manage a severe coagulation disorder during surgical pulmonary embolectomy performed under cardiopulmonary bypass.
- 650 _2
- $a koagulopatie $x komplikace $x farmakoterapie $7 D001778
- 650 _2
- $a koagulancia $x aplikace a dávkování $7 D003029
- 650 _2
- $a embolektomie $x škodlivé účinky $7 D017128
- 650 _2
- $a faktor VII $x aplikace a dávkování $x genetika $7 D005167
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pooperační krvácení $x etiologie $x prevence a kontrola $7 D019106
- 650 _2
- $a plicní embolie $x komplikace $x chirurgie $7 D011655
- 650 _2
- $a rekombinantní proteiny $x škodlivé účinky $7 D011994
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Harrer, Jan $u -
- 700 1_
- $a Brtko, Miroslav $u -
- 700 1_
- $a Habal, Petr $u -
- 700 1_
- $a Turek, Zdenek $u -
- 700 1_
- $a Pojar, Marek $u -
- 700 1_
- $a Brozik, Jan $u -
- 773 0_
- $w MED00181085 $t The heart surgery forum $x 1522-6662 $g Roč. 16, č. 4 (2013), s. E205-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23958532 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140410105123 $b ABA008
- 999 __
- $a ok $b bmc $g 1017979 $s 849423
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 16 $c 4 $d E205-7 $i 1522-6662 $m The heart surgery forum $n Heart Surg Forum $x MED00181085
- LZP __
- $a Pubmed-20140401
